Homocysteine and arteriosclerosis - Subclinical and clinical disease associations

被引：53
作者：
Bostom, AG
Selhub, J
机构：
[1] Mem Hosp Rhode Isl, Div Gen Internal Med, Providence, RI USA
[2] Tufts Univ, USDA, Human Nutr Res Ctr, Vitamin Bioavailabil Lab, Boston, MA 02111 USA
来源：
CIRCULATION | 1999年 / 99卷 / 18期
关键词：
editorials; arteriosclerosis; homocysteine; risk factors;
D O I：
10.1161/01.CIR.99.18.2361
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2361 / 2363
页数：3
相关论文
共 44 条
[1]  
A'Brook R., 1998, European Heart Journal, V19, P8
[2]   Association between plasma homocysteine and extracranial carotid arterial disease in older persons [J].
Aronow, WS ;
Ahn, C ;
Schoenfeld, MR .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (10) :1432-&
[3]  
BERESFORD SAA, 1997, PREVENTIVE NUTR COMP, P193
[4]   Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients - A prospective study [J].
Bostom, AG ;
Shemin, D ;
Verhoef, P ;
Nadeau, MR ;
Jacques, PF ;
Selhub, J ;
Dworkin, L ;
Rosenberg, IH .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2554-2558
[5]  
BOSTOM AG, IN PRESS ARCH INTERN
[6]   Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam Study [J].
Bots, ML ;
Launer, LJ ;
Lindemans, J ;
Hofman, A ;
Grobbee, DE .
JOURNAL OF INTERNAL MEDICINE, 1997, 242 (04) :339-347
[7]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[8]   Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease -: The result of a meta-analysis [J].
Brattström, L ;
Wilcken, DEL ;
Öhrvik, J ;
Brudin, L .
CIRCULATION, 1998, 98 (23) :2520-2526
[9]   Acute hyperhomocysteinaemia and endothelial dysfunction [J].
Chambers, JC ;
McGregor, A ;
Jean-Marie, J ;
Kooner, JS .
LANCET, 1998, 351 (9095) :36-37
[10]  
Clarke R, 1998, J Cardiovasc Risk, V5, P249, DOI 10.1097/00043798-199808000-00007
12345